These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9139993)

  • 1. A novel model of conduit coronary constriction reveals local actions of endothelin-1 and prostaglandin F2alpha.
    Rigel DF; Shetty SS
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H2054-64. PubMed ID: 9139993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditioning of coronary artery against vasoconstriction by endothelin-1 and prostaglandin F2alpha during repeated downregulation of epsilon-protein kinase C.
    Kanashiro CA; Altirkawi KA; Khalil RA
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):491-501. PubMed ID: 10710137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilation and constriction of large coronary arteries in conscious dogs by endothelin.
    Wang J; Zeballos GA; Kaley G; Hintze TH
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1379-86. PubMed ID: 1951724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F2alpha and E2) in isolated guinea pig hearts.
    Möbert J; Becker BF; Zahler S; Gerlach E
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):789-94. PubMed ID: 9234660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of endothelin-induced vasoconstriction by endothelium-dependent and -independent vasodilators in isolated hearts and vascular rings.
    Stowe DF; O'Brien WC; Chang D; Knop CS; Kampine JP
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):747-54. PubMed ID: 9234655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 limits increases in blood flow to native and collateral-dependent myocardium.
    Symons JD; Rendig SV; Fu LW; Longhurst JC
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R41-8. PubMed ID: 9249531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow.
    Salvati P; Chierchia S; Dho L; Ferrario RG; Parenti P; Vicedomini G; Patrono C
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):1007-14. PubMed ID: 1714004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constriction of canine coronary arteries by platelet activating factor after brief ischemia.
    Kim YD; Danchak RM; Heim KF; Lees DE; Myers AK
    Prostaglandins; 1993 Sep; 46(3):269-76. PubMed ID: 8234834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of prostaglandin F2alpha on the systemic and regional hemodynamics of dogs].
    Flerov EV; Ismailov ShI
    Farmakol Toksikol; 1977; 40(1):44-50. PubMed ID: 852545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
    Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine induces constriction of epicardial coronary arteries in anesthetized dogs after removal of endothelium.
    Schipke JD; Heusch G; Deussen A; Thämer V
    Arzneimittelforschung; 1985; 35(6):926-9. PubMed ID: 4026918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin causes contraction of canine and bovine arterial smooth muscle in vitro and in vivo.
    Suzuki Y; Satoh S; Ikegaki I; Asano T; Shibuya M; Sugita K; Lederis K; Rorstad O
    Acta Neurochir (Wien); 1990; 104(1-2):42-7. PubMed ID: 2201171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms.
    Khalil A; Carrier M; Latour JG; Pelletier LC
    Circulation; 1996 Nov; 94(9 Suppl):II308-11. PubMed ID: 8901766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.
    Wang QD; Li XS; Lundberg JM; Pernow J
    Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low doses of endothelin-1 on basal vascular tone and autoregulatory vasodilation in canine coronary microcirculation in vivo.
    Wang Y; Kanatsuka H; Akai K; Sugimura A; Kumagai T; Komaru T; Sato K; Shirato K
    Jpn Circ J; 1999 Aug; 63(8):617-23. PubMed ID: 10478812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects.
    Kiss O; Zima E; Soós P; Kékesi V; Juhász-Nagy A; Merkely B
    Life Sci; 2004 Jun; 75(5):537-48. PubMed ID: 15158364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine preconditions against endothelin-induced constriction of coronary arterioles.
    Merkus D; Stepp DW; Jones DW; Nishikawa Y; Chilian WM
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2593-7. PubMed ID: 11087209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans.
    Pernow J; Kaijser L; Lundberg JM; Ahlborg G
    Circulation; 1996 Nov; 94(9):2077-82. PubMed ID: 8901654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endothelin-1 on epicardial coronary tone, coronary blood flow, ECG-ST change and regional wall motion in anesthetized dogs.
    Muramatsu K; Tomoike H; Ohara Y; Egashira S; Nakamura M
    Heart Vessels; 1991; 6(4):191-6. PubMed ID: 1800477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 promotes Ca2+ antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-protein kinase C.
    McNair LL; Salamanca DA; Khalil RA
    Hypertension; 2004 Apr; 43(4):897-904. PubMed ID: 14981072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.